The Best of 2020: The RA Report
February 10, 2021|Rheumatology
Read this supplement to Rheumatology News here.
In this issue:
- Synovial biopsy findings drive precision medicine closer to the clinic
- Ready for PRIME time? Newly identified cells predict flares
- Rheumatologists’ prescriptions of biosimilars stagnate
- Methotrexate in terms of ILD concerns, poor adherence, and low-dose AEs 10-13 TNF inhibitors linked to risk for inflammatory CNS events
- Hypersensitivity reactions to biologics differentiated
- Repeat latent TB testing focuses on new risks